Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-15

FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

The FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories, L.P. This action typically accompanies labeling chang…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBEX (clobetasol propionate)

Snippet

SUPPL AP for CLOBEX (CLOBETASOL PROPIONATE)